Korsana Biosciences KRSA
NASDAQ KRSA
$32.68 +0.14 (+0.43%)
As of: Oct 22, 2026 · 11:15 AM EDT

Korsana Biosciences (KRSA) Other Non-Current Liabilities (2019)

Updated

Korsana Biosciences (KRSA) posted Other Non-Current Liabilities of $52,000 for Q1 2019.

Analysis

Korsana Biosciences (KRSA) Other Non-Current Liabilities (2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,172.45 Bn 1,141.04 Bn 19.71 Bn
2 Johnson & Johnson 637.59 Bn 556.11 Bn 17.26 Bn
3 AbbVie 504.05 Bn 477.16 Bn 12.70 Bn
4 Merck 377.18 Bn 331.56 Bn 12.21 Bn
5 Novartis Ag 304.13 Bn 268.12 Bn 11.24 Bn
6 Astrazeneca 267.62 Bn 241.31 Bn 12.86 Bn
7 Amgen 241.83 Bn 197.23 Bn 7.24 Bn
8 Gilead Sciences 194.07 Bn 168.27 Bn 6.22 Bn
9 Pfizer 172.51 Bn 119.15 Bn 10.94 Bn
10 Korsana Biosciences 15.06 Mn 603,133.66 -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 52,000.00
API Access

Korsana Biosciences Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=KRSA&period=max&api_key=YOUR_API_KEY